Health and Waste Notices




27 OCTOBER 2011 NEW ZEALAND GAZETTE, No. 163 4609

  • the nominee’s CV and contact details; and
  • contact details for three referees.

CVs should include all information as is found on the
Cabinet Appointments and Honours Committee CV
template available for download at
www.dpmc.govt.nz/cabinet/forms/index.html

All nominations will be forwarded to the Minister for the
Environment for consideration.

Nominations close at 5.00pm on 28 November 2011.

For further information refer to the Ministry for the
Environment website
www.mfe.govt.nz/issues/waste/advisory-board/
or contact the Waste and Resources Team at the Ministry
for the Environment on telephone (04) 439 7400 or email
nominations@mfe.govt.nz

Nominations can be emailed to nominations@mfe.govt.nz
or posted to Waste Advisory Board nominations, Ministry
for the Environment, PO Box 10362, Wellington 6143.

go7426


Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new medicines set out in the Schedule hereto:

Schedule

Product: Emend IV
Active Ingredient: Fosaprepitant dimeglumine 257.6mg
Dosage Form: Powder for injection
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: DSM Pharmaceuticals Inc, North Carolina, United States of America

Product: Nurofen Sinus Pain PE (General Sale)
Active Ingredients: Ibuprofen 200mg
Phenylephrine hydrochloride 5mg equivalent to Phenylephrine 4.1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: Reckitt Benckiser Healthcare International Limited, Nottinghamshire, United Kingdom

Product: Nurofen Sinus Pain PE (Pharmacy Only)
Active Ingredients: Ibuprofen 200mg
Phenylephrine hydrochloride 5mg equivalent to Phenylephrine 4.1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: Reckitt Benckiser Healthcare International Limited, Nottinghamshire, United Kingdom

Product: Orencia
Active Ingredient: Abatacept 262.5mg
Dosage Form: Powder for injection
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico

Product: Penembact
Active Ingredient: Meropenem trihydrate 570.5mg equivalent to Meropenem 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: InterPharma (NZ) Limited
Manufacturer: Venus Remedies Limited/India, Baddi (H.P), India

Product: Penembact
Active Ingredient: Meropenem trihydrate 1141mg equivalent to Meropenem 1000mg
Dosage Form: Powder for injection
New Zealand Sponsor: InterPharma (NZ) Limited
Manufacturer: Venus Remedies Limited/India, Baddi (H.P), India

Product: Robitussin Mucus Relief Double Action
Active Ingredients: Bromhexine hydrochloride 0.8mg/mL
Guaifenesin 20mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Interphil Laboratories Inc, Laguna, Philippines



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2011, No 163





✨ LLM interpretation of page content

Call for Waste Advisory Board Nominations (continued from previous page)

Environment
Waste Advisory Board, Nominations, Waste Minimisation Act 2008

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
Medicines Act, New Medicines, Distribution Consent, Pharmaceuticals
  • Minister of Health